Coloplast A/S
CSE:COLO B

Watchlist Manager
Coloplast A/S Logo
Coloplast A/S
CSE:COLO B
Watchlist
Price: 786 DKK 0.69% Market Closed
Market Cap: 176.9B DKK
Have any thoughts about
Coloplast A/S?
Write Note

Operating Margin
Coloplast A/S

27%
Current
30%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
27%
=
Operating Profit
7.3B
/
Revenue
27B

Operating Margin Across Competitors

Country DK
Market Cap 177.1B DKK
Operating Margin
27%
Country JP
Market Cap 7T JPY
Operating Margin
28%
Country CH
Market Cap 38.2B CHF
Operating Margin
13%
Country US
Market Cap 16.3B USD
Operating Margin
17%
Country KR
Market Cap 10.3T KRW
Operating Margin
-245%
Country CN
Market Cap 51B CNY
Operating Margin
45%
Country US
Market Cap 6.7B USD
Operating Margin
32%
Country CA
Market Cap 6.3B USD
Operating Margin
4%
Country UK
Market Cap 4.6B GBP
Operating Margin
13%
Country US
Market Cap 5.6B USD
Operating Margin
12%
Country CH
Market Cap 4.7B CHF
Operating Margin
14%
No Stocks Found

Coloplast A/S
Glance View

Economic Moat
None
Market Cap
177.1B DKK
Industry
Health Care

Coloplast A/S, headquartered in Humlebæk, Denmark, has a storied history that dates back to 1954 when a nurse, Elise Sørensen, identified a crucial need in the healthcare sector. Her sister had undergone ostomy surgery, and the lack of appropriate post-operative care products inspired Sørensen to design the world’s first adhesive ostomy bag. This innovation laid the groundwork for Coloplast's trajectory in the healthcare industry. Today, the company has expanded its focus to include ostomy care, continence care, wound and skin care, and interventional urology. With a commitment to improving patients' quality of life, Coloplast has become a leader in designing and manufacturing products that not only highlight practicality but also embody comfort and discretion. Coloplast generates revenue through a business model that emphasizes product innovation and direct engagement with healthcare providers and patients. The company invests significantly in research and development to improve and widen its product offerings continuously. It operates globally, distributing its products directly and via partnerships with hospitals, clinics, and healthcare professionals. By maintaining an attentive approach to user experience and incorporating customer feedback into its development processes, Coloplast ensures its portfolio aligns with the actual needs of its users. This user-centered strategy not only enhances customer loyalty but also fortifies the company’s market position, driving its financial success.

COLO B Intrinsic Value
832.39 DKK
Undervaluation 6%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
27%
=
Operating Profit
7.3B
/
Revenue
27B
What is the Operating Margin of Coloplast A/S?

Based on Coloplast A/S's most recent financial statements, the company has Operating Margin of 27%.